​​​​​Stellenbosch University Immunology Research Group

Publications

20​08

1. Biomarkers for TB treatment response: challenges and future strategies.

Walzl G, Ronacher K, Djoba Siawaya JF, Dockrell HM. J Infect. 2008 Aug;57(2):103-9

http://www.ncbi.nlm.nih.gov/pubmed/18649943

2. An evaluation of commercial fluorescent bead-based luminex cytokine assays.

Djoba Siawaya JF, Roberts T, Babb C, Black G, Golakai HJ, Stanley K, Bapela NB, Hoal E, Parida S, van Helden P, Walzl G.PLoS One. 2008 Jul 2;3(7):e2535.

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002535

3. Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment.

Djoba Siawaya JF, Bapela NB, Ronacher K, Beyers N, van Helden P, Walzl G. Clin Vaccine Immunol. 2008 Aug;15(8):1165-70.

http://www.ncbi.nlm.nih.gov/pubmed/18579694

4. Evaluation of adapted whole-blood interferon-gamma release assays for the diagnosis of pleural tuberculosis.

Chegou NN, Walzl G, Bolliger CT, Diacon AH, van den Heuvel MM. Respiration. 2008;76(2):131-8

http://www.ncbi.nlm.nih.gov/pubmed/18434705

5. High level of discordant IGRA results in HIV-infected adults and children.

Mandalakas AM, Hesseling AC, Chegou NN, Kirchner HL, Zhu X, Marais BJ, Black GF, Beyers N, Walzl G. Int J Tuberc Lung Dis. 2008 Apr;12(4):417-23.

http://www.ncbi.nlm.nih.gov/pubmed/18371268

6. Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response.

Djoba Siawaya JF, Bapela NB, Ronacher K, Veenstra H, Kidd M, Gie R, Beyers N, van Helden P, Walzl G. J Infect. 2008 May;56(5):340-7.

http://www.ncbi.nlm.nih.gov/pubmed/18359089

7. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.

Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, Black G, Hassan HY, Wilkinson RJ, Walzl G, Gelderbloem SJ, Mahomed H, Hussey GD, Hanekom WA. J Immunol. 2008 Feb 1;180(3):1962-70.

http://www.ncbi.nlm.nih.gov/pubmed/18209095

8. High levels of intracellular IL-4 are expressed in circulating apoptotic T cells in patients with tuberculosis and in community controls.

Veenstra H, Baumann R, Lukey PT, Beyers N, van Helden PD, Walzl G. Tuberculosis (Edinb). 2008 Jan;88(1):21-30.

http://www.ncbi.nlm.nih.gov/pubmed/17977794